NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/18/2025
Back to search
Official data from USPTO
GREENWICH BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GREENWICH BIOSCIENCES
ST13
US500000099058243Class
5
Filing
99058243
Registration
8028682
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
11/19/2025
Trademark type
Word
Nice classes
5
Filing date
02/26/2025
Registration date
11/18/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/18/2025
Last transaction
11/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Kent, GB
Examiner
PHILLIPS,ALEXANDER J
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Jazz Pharmaceuticals Operations UK Limited
Representatives
Michael T. Olsen Winthrop & Weinstine, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of painneuropathic paincancer painperioperative paincancer symptomsmultiple sclerosis (MS)spasticityMS spasticityconvulsionsseizuresepilepsypaediatric epilepsyintractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC)generalised epilepsy with febrile seizures plus (GEFS positive)dup 15Doose syndromefor use in oncology; pharmaceutical preparations and substances for the treatment of bladder dysfunctioninflammatory bowel diseaseulcerative colitisCrohn's diseaseAlzheimer'sDravet syndromeLennoxGastaut syndrome (LGS)spinal cord injuryhead injurybone disorderschromosome disordersinflammatory disordersinflammationarthritis; pharmaceutical preparations and substances for the treatment of metabolic disorderscancer symptomsneurodegenerative diseasesdiseases of the central nervous systemperipheral neuropathyneurogenic symptomshypoxicischemic encephalopathyneonatal hypoxic encephalopathystrokemotion sickness and chemically induced sickness and for the use in oncology; pharmaceutical preparations and substances for the treatment of diabetestype II diabetesobesityobesity associated with diabetesbulimiapsychiatric disordersschizophreniadrugalcohol and nicotine abuseautism; herbs for medicinal purposes; medicinal herbs; medicinal infusions for treating painneuropathic paincancer painperi-operative paincancer symptomsmultiple sclerosisspasticityMS spasticityconvulsionsseizuresepilepsypaediatric epilepsyintractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC)generalised epilepsy with febrile seizures plus (GEFS positive)dup 15Doose syndrome and for use in oncology; medicinal infusions for treating bladder dysfunctioninflammatory bowel diseaseulcerative colitisCrohn's diseaseAlzheimer'sDravet syndromeLennoxGastaut syndrome (LGS)spinal cord injuryhead injurybone disorderschromosome disordersinflammatory disordersinflammationarthritis; medicinal infusions for treating metabolic disorderscancer symptomsneurodegenerative diseasesdiseases of the central nervous systemperipheral neuropathyneurogenic symptomshypoxicischemic encephalopathyneonatal hypoxic encephalopathystrokemotion sickness and chemically induced sickness and for use in oncology; medicinal infusions for treating diabetestype II diabetesobesityobesity associated with diabetesbulimiapsychiatric disordersschizophreniadrugalcohol and nicotine abuseautism; pure extracts of medicinal plants and herbs other than essential oils for medicalveterinary and pharmaceutical purposes; foodstuffs for medicinal purposesmedicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/30/2025
PUBO
PUBLISHED FOR OPPOSITION
09/30/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/29/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/08/2025
GNRT
NON-FINAL ACTION E-MAILED
08/08/2025
CNRT
NON-FINAL ACTION WRITTEN
08/08/2025
DOCK
ASSIGNED TO EXAMINER
07/31/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/26/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/26/2025
NWAP
NEW APPLICATION ENTERED
02/26/2025
Continuous trademark protection
Get notified about every new filing that threatens GREENWICH BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.